EFIMOSFERMIN
GSK to buy liver disease drug from Boston Pharmaceuticals for up to $2 billionGSK is set to acquire efimosfermin, a promising liver disease drug, from Boston Pharmaceuticals for a potential $2 billion. The deal includ...
- Load More
'Let us wail!' Iranians flock to Khamenei's funeral after wartime death
India tightens scrutiny of Chinese herbicide imports
Govt scraps TDS on GIFT City aircraft lease rentals
Dad-dancing Djokovic embraces the fun of the road to Major No. 25
Norway pin hopes on Haaland against Brazil in World Cup last 16
Eastward ho! Indian travellers give West a miss
England enter World Cup lion's den as Mexico host them at Azteca fortress
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service